[Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].
D000284:Administration, Oral; D000328:Adult; D001247:Asthenia / Q000139:chemically induced; D001729:Bismuth / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D001927:Brain Diseases / Q000139:chemically induced*; D003072:Cognition Disorders / Q000139:chemically induced; D003221:Confusion / Q000139:chemically induced; D003248:Constipation / Q000188:drug therapy; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000139:chemically induced; D009566:Nitrates / Q000009:adverse effects; D010554:Personality Disorders; D011247:Pregnancy; D012651:Self Medication; D013064:Speech Disorders / Q000139:chemically induced; D019966:Substance-Related Disorders
D009566:Nitrates; D001729:Bismuth
Encøephalopathies myocloniques par les sels de bismuth. Six cas observés lors de traitements oraux au long cours